Related references
Note: Only part of the references are listed.Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Alison G. Freifeld et al.
CLINICAL INFECTIOUS DISEASES (2011)
Which AML Subsets Benefit From Leukemic Cell Priming During Chemotherapy? Long-Term Analysis of the ALFA-9802 GM-CSF Study
Xavier Thomas et al.
CANCER (2010)
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study
Catherine Cordonnier et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
Is BAL useful in patients with acute myeloid leukemia admitted in ICU for severe respiratory complications?
A. Rabbat et al.
LEUKEMIA (2008)
Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: Systematic review and meta-analysis
Eyal Robenshtok et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Fungal infections in recipients of hematopoietic stem cell transplants: Results of the SEIFEM B-2004 study - Sorveglianza epidemiologica infezioni fungine nelle emopatie maligne
L. Pagano et al.
CLINICAL INFECTIOUS DISEASES (2007)
Bacteraernia in febrile neutropenic cancer patients
J. Klastersky et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia:: a trial by the Acute Leukemia French Association (ALFA) Group
X. Thomas et al.
LEUKEMIA (2007)
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
Oliver A. Cornely et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Diarrhea in neutropenic patients: a prospective cohort study with emphasis on neutropenic enterocolitis
D. Y. Aksoy et al.
ANNALS OF ONCOLOGY (2007)
Invasive fungal infections in neutropenic enterocolitis: A systematic analysis of pathogens, incidence, treatment and mortality in adult patients
M Gorschluter et al.
BMC INFECTIOUS DISEASES (2006)
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial
BJ Kullberg et al.
LANCET (2005)
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia
G Bucaneve et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Chemotherapy-induced neutropenia - Risks, consequences, and new directions for its management
J Crawford et al.
CANCER (2004)
Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93
T Lehrnbecher et al.
LEUKEMIA (2004)
Randomized comparison of double induction and timed-sequential induction to a 3+7 induction in adults with AML:: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study
S Castaigne et al.
BLOOD (2004)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2003)
Epidemiology and risk factors for gram-positive coccal infections in neutropenia: Toward a more targeted antibiotic strategy
C Cordonnier et al.
CLINICAL INFECTIOUS DISEASES (2003)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
S Ascioglu et al.
CLINICAL INFECTIOUS DISEASES (2002)
The cost of treating systemic fungal infections
R van Gool
DRUGS (2001)
Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia
TA Madani
INFECTION (2000)
Share Paper
